scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0140-6736(51)91643-1 |
P698 | PubMed publication ID | 14874500 |
P2093 | author name string | F PAGE | |
P433 | issue | 6687 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | lupus erythematosus | Q188297 |
P304 | page(s) | 755-758 | |
P577 | publication date | 1951-10-01 | |
P1433 | published in | The Lancet | Q939416 |
P1476 | title | Treatment of lupus erythematosus with mepacrine | |
P478 | volume | 2 |
Q69399379 | A Reappraisal of Oral Quinine in Discoid Lupus Erythematosus |
Q50059772 | A bibliometric review of drug repurposing |
Q41946120 | Amodiaquine and hydroxychloroquine in rheumatoid arthritis |
Q39990460 | An appraisal of chloroquine |
Q72636802 | Antimalarials |
Q40332551 | Antimalarials and ophthalmologic safety |
Q39772563 | Antimalarials in the management of discoid and systemic lupus erythematosus |
Q78642719 | Antimalarials in treatment of Sjogren's syndrome |
Q34129797 | Antimalarials. |
Q33853468 | Antimalarials: unapproved uses or indications |
Q73728364 | Aplastic anaemia following mepacrine treatment of lupus erythematosus |
Q73066689 | Atabrine in the treatment of discoid lupus erythematosus |
Q41947452 | Atebrine and chloroquine/resochin therapy of lupus erythematous and dermatoses due to photosensitivity |
Q41945107 | Bilateral Macular Degeneration Associated with Chloroquine Therapy* |
Q35743410 | Central scotomata following chloroquine therapy |
Q41945745 | Changes in the human electro-retinogram during long-term resochin therapy |
Q33570457 | Chloroquine and rheumatoid arthritis; a short-term controlled trial |
Q33570876 | Chloroquine diphosphate in rheumatoid arthritis. A controlled trial |
Q36861541 | Chloroquine ototoxicity |
Q85020598 | Chloroquine psychosis |
Q73713853 | Chloroquine sulphate in treatment of chronic discoid lupus erythematosus |
Q35664483 | Controversies in the treatment of rheumatoid arthritis |
Q40212123 | Current status of disease-modifying drugs in progressive rheumatoid arthritis |
Q37782472 | Cutaneous lupus erythematosus: Update of therapeutic options |
Q36005283 | Discussion on the collagen vascular diseases |
Q34357618 | Disease modifying drugs for rheumatoid arthritis: yesterday's treatment today or today's treatment tomorrow? |
Q55477738 | Disturbances of pigmentation with chloroquine. |
Q91934535 | Drug repurposing to improve treatment of rheumatic autoimmune inflammatory diseases |
Q41937626 | Electroretinography in Patients with Connective Tissue Diseases Treated with Hydroxychloroquine |
Q97646016 | Hydroxychloroquine in Dermatology and Beyond: Recent Update |
Q40152521 | Hydroxychloroquine sulfate in rheumatoid arthritis: Long-term response rate and predictive parameters |
Q26782822 | Hydroxychloroquine-related retinal toxicity |
Q37827403 | Hydroxychloroquine: from malaria to autoimmunity |
Q76807490 | LUPUS ERYTHEMATOSUS |
Q41947565 | Light sensitive eruptions treated with atabrine and chloroquine |
Q35547553 | Long-term effectiveness of antimalarial drugs in rheumatic diseases |
Q28331277 | Marrow transplantation for severe aplastic anemia associated with exposure to quinacrine |
Q76282617 | Mepacrine and rheumatoid arthritis |
Q37369932 | Multifocal electroretinography after high dose chloroquine therapy for malaria |
Q89285609 | Neuropsychiatric clinical manifestations in elderly patients treated with hydroxychloroquine: a review article |
Q34007922 | New concepts in antimalarial use and mode of action in dermatology |
Q33652585 | New hopes from old drugs: revisiting DNA-binding small molecules as anticancer agents |
Q69829422 | Non-steroidal anti-inflammatory drugs |
Q78836545 | On visual disturbances and eye changes in quinoline therapy of primary chronic articular rheumatism |
Q41944252 | PERIPHERAL NEUROPATHY FOLLOWING CHLOROQUINE THERAPY |
Q76497813 | Photosensitivity Reactions in Various Diseases |
Q47874310 | Quinacrine for extremity melanoma in a mouse model of isolated limb perfusion (ILP). |
Q37415122 | RETINOPATHY DURING CHLOROQUINE THERAPY. |
Q41943431 | RH ANTIBODY FORMATION UNDER THE INFLUENCE OF CHLOROQUINE DIPHOSPHATE AND SODIUM SALICYLATE MEDICATION |
Q74658507 | Rationale for the treatment of lupus erythematosus with antimalarials |
Q41929959 | Recent therapeutic advances in dermatology |
Q35645066 | Remission-inducing drugs in rheumatoid arthritis |
Q40162233 | Remission-inducing therapy in rheumatoid arthritis |
Q35764302 | Response to antimalarial agents in cutaneous lupus erythematosus: a prospective analysis |
Q78766793 | Retinopathy following chloroquine therapy |
Q42174496 | Synthetic antimalarial drug therapy in lupus erythematosus and polymorphous light eruptions. |
Q74603497 | Systemic lupus erythematosus |
Q40090535 | Systemic lupus erythematosus: 25 years of treatment related to immunopathology. |
Q35854161 | THE VALUE AND DANGERS OF ANTIMALARIAL THERAPY IN ARTHRITIS WITH SPECIAL RELATION TO OPHTHALMIC COMPLICATIONS |
Q68322558 | The Gold Standard in Rheumatoid Arthritis |
Q41947536 | The use of chloroquine diphosphate (aralen) and quinacrine (atabrine) hydrochloride in the prevention of polymorphorus light eruptions. |
Q35682095 | The value of chloroquine in rheumatoid disease: a four-year study of continuous therapy |
Q73066692 | Therapeutic assays of the Skin and Cancer Unit of the New York University Hospital. Assay VII-Quinacrine hydrochloride (atabrine hydrochloride) for chronic discoid lupus erythematosus |
Q38561490 | Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases |
Q73582114 | Thrombotic thrombocytopenic purpura; report of a case |
Q73066697 | Treatment of chronic discoid lupus erythematosus with atabrine |
Q78372139 | Treatment of rheumatoid arthritis with chloroquine |
Q53569313 | Treatment of systemic lupus erythematosus: from cod-liver oil to cyclosporin. |
Q41921039 | Use of synthetic antimalarial drugs and other agents for rheumatoid arthritis: Historic and therapeutic perspectives |
Q84600129 | [Antimalarials: an update in rheumatic diseases] |
Q79243061 | [On the neurological syndrome in the framework of lupus erythematosus] |
Search more.